Funding

Leyden Laboratories

Netherlands · Biotech · Healthtech · Enterprise software

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

Visit leydenlabs.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B€40MClavystBio — Role not disclosedEuropean Innovation Council (EIC) Fund — Role not disclosedGates Foundation — Role not disclosedInvest-NL — Role not disclosed

Investors

ClavystBioSeries BEuropean Innovation Council (EIC) FundSeries BGates FoundationSeries BInvest-NLSeries B

Coverage

Jun 25, 2026Leyden Laboratories · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcesprojectstartups.com ↗